Newly-launched drugs enjoy a year of free pricing in Germany, before the country’s AMNOG cost-effectiveness system assesses their benefits compared with standard care and sets a price.

For instance, we are seeing increasingly regionalised market access in Italy, a highly challenging pricing environment in France, and the introduction of AMNOG in Germany – they are playing ...

U.S. 10 Year Treasury Note 0.0130 4.3100% ...